144 related articles for article (PubMed ID: 37787384)
1. A genetic variant in gene NDUFAF4 confers the risk of non-small cell lung cancer by perturbing hsa-miR-215 binding.
Long T; Li J; Yin T; Liu K; Wang Y; Long J; Wang J; Cheng L
Mol Carcinog; 2024 Jan; 63(1):145-159. PubMed ID: 37787384
[TBL] [Abstract][Full Text] [Related]
2. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
3. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
[TBL] [Abstract][Full Text] [Related]
4. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
5. MiR-181a reduces radiosensitivity of non-small-cell lung cancer via inhibiting PTEN.
Chen Y; Liao W; Yuan A; Xu H; Yuan R; Cao J
Panminerva Med; 2022 Sep; 64(3):374-383. PubMed ID: 32506887
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics identification of miR-514b-5p promotes NSCLC progression and induces PI3K/AKT and p38 pathways by targeting small glutamine-rich tetratricopeptide repeat-containing protein beta.
Shi L; Kan J; Zhuo L; Wang S; Chen S; Zhang B; Ke B
FEBS J; 2023 Feb; 290(4):1134-1150. PubMed ID: 36180981
[TBL] [Abstract][Full Text] [Related]
7. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
9. NEAT1/hsa-mir-98-5p/MAPK6 axis is involved in non-small-cell lung cancer development.
Wu F; Mo Q; Wan X; Dan J; Hu H
J Cell Biochem; 2019 Mar; 120(3):2836-2846. PubMed ID: 29095526
[TBL] [Abstract][Full Text] [Related]
10. hsa_circ_0003176 Suppresses the Progression of Non-Small-Cell Lung Cancer via Regulating miR-182-5p/RBM5 Axis.
Yang F; Pei Y; Xu W; Rong L
Dis Markers; 2022; 2022():8402116. PubMed ID: 36193508
[TBL] [Abstract][Full Text] [Related]
11. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
Yang W; Xie T
Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway.
Fan X; Wu X
J BUON; 2019; 24(1):273-279. PubMed ID: 30941980
[TBL] [Abstract][Full Text] [Related]
13. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN.
Li H; Huhe M; Lou J
Biomed Res Int; 2021; 2021():7590976. PubMed ID: 34307670
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
[TBL] [Abstract][Full Text] [Related]
16. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo.
Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H
Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0006692 Promotes Lung Cancer Progression via miR-205-5p/CDK19 Axis.
Liao J; Chen Z; Luo X; Su Y; Huang T; Xu H; Lin K; Zheng Q; Zhang L; Lin G; Lin X
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627232
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0069244 acts as the sponge of miR-346 to inhibit non-small cell lung cancer progression by regulating XPC expression.
Shi J; Wang H; Feng W; Huang S; An J; Wang L; Jiang J
Hum Cell; 2021 Sep; 34(5):1490-1503. PubMed ID: 34228324
[TBL] [Abstract][Full Text] [Related]
19. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA hsa_circ_0000317 inhibits non-small cell lung cancer progression through regulating microRNA-494-3p/phosphatase and tensin homolog deleted on chromosome 10 axis.
Xia S; Zhang Z
Clinics (Sao Paulo); 2022; 77():100086. PubMed ID: 35917658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
